PIERIS PHARMACEUTICALS, INC. 4
4 · PIERIS PHARMACEUTICALS, INC. · Filed Feb 17, 2016
Insider Transaction Report
Form 4
Yoder Stephen S.
DirectorCEO and President
Transactions
- Award
Stock Option (right to buy)
2016-02-12+492,000→ 492,000 totalExercise: $1.52Exp: 2026-02-12→ Common Stock (492,000 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the option shares on February 12, 2017 and vests as to an additional 6.25% of the option shares at the end of each successive three-month period thereafter until February 12, 2020.